bf/NASDAQ:BTAI_icon.jpeg

NASDAQ:BTAI

BioXcel Therapeutics, Inc.

  • Stock

USD

Last Close

1.17

26/07 20:00

Market Cap

41.28M

Beta: 1.10

Volume Today

258.96K

Avg: 506.97K

PE Ratio

−0.51

PFCF: −0.67

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
375K
-
1.38M
268%
cost of revenue
156K
-
188K
20.51%
297K
57.98%
20K
93.27%
1.58M
7,790.00%
gross profit
-156K
-
-188K
20.51%
-297K
57.98%
355K
219.53%
-198K
155.77%
selling and marketing expenses
13.01M
-
12.48M
4.01%
general and administrative expenses
721K
-
1.85M
156.17%
5.40M
192.58%
7.80M
44.41%
24.30M
211.40%
54.23M
123.14%
68.76M
26.80%
70.93M
3.15%
selling general and administrative expenses
721K
-
1.85M
156.17%
5.40M
192.58%
7.80M
44.41%
24.30M
211.40%
54.23M
123.14%
68.76M
26.80%
83.20M
21.00%
research and development expenses
1.40M
-
2.69M
92.28%
14.56M
441.19%
25.80M
77.20%
57.99M
124.81%
52.71M
9.12%
91.24M
73.10%
82.93M
9.10%
other expenses
-427K
-
394K
192.27%
cost and expenses
2.12M
-
4.54M
114.01%
19.96M
339.98%
33.60M
68.32%
82.30M
144.92%
106.94M
29.94%
160.02M
49.64%
167.71M
4.81%
operating expenses
2.12M
-
4.54M
114.01%
19.96M
339.98%
33.60M
68.32%
82.30M
144.92%
106.94M
29.94%
160M
49.62%
166.13M
3.83%
interest expense
2K
-
27K
-
40K
48.15%
8.21M
20,432.50%
13.31M
62.11%
ebitda
-2.12M
-
-4.54M
113.96%
-20.64M
354.96%
-34.08M
65.13%
-82.30M
141.50%
-106.94M
29.94%
-157.54M
47.33%
-166.01M
5.38%
operating income
-2.12M
-
-4.54M
114.01%
-19.96M
339.98%
-33.60M
68.32%
-82.30M
144.92%
-106.94M
29.94%
-159.65M
49.29%
-166.33M
4.19%
depreciation and amortization
1K
-
17K
1,600%
-477K
2,905.88%
188K
139.41%
297K
57.98%
2.10M
607.41%
318K
84.86%
total other income expenses net
-2K
-
692K
34,700%
633K
8.53%
128K
79.78%
4K
96.88%
-6.11M
152,900%
-12.72M
108.12%
income before tax
-2.12M
-
-4.54M
114.10%
-19.27M
324.54%
-32.97M
71.08%
-82.17M
149.24%
-106.93M
30.14%
-165.76M
55.01%
-179.05M
8.02%
income tax expense
692K
-
-633K
191.47%
-161K
74.57%
-301K
86.96%
6.09M
2,123.92%
net income
-2.12M
-
-4.54M
114.10%
-19.27M
324.54%
-32.34M
67.80%
-82.01M
153.62%
-106.63M
30.02%
-171.85M
61.16%
-179.05M
4.19%
weighted average shs out
15.65M
-
15.19M
2.91%
14.57M
4.08%
16.29M
11.79%
21.68M
33.11%
26.37M
21.63%
28.02M
6.23%
29.13M
3.98%
weighted average shs out dil
15.65M
-
15.19M
2.91%
14.57M
4.08%
16.29M
11.79%
21.68M
33.11%
26.37M
21.63%
28.02M
6.23%
29.13M
3.98%
eps
-0.14
-
-0.30
114.29%
-1.32
340.00%
-1.99
50.76%
-3.78
89.95%
-4.04
6.88%
-6.13
51.73%
-6.15
0.33%
epsdiluted
-0.14
-
-0.30
114.29%
-1.32
340.00%
-1.99
50.76%
-3.78
89.95%
-4.04
6.88%
-6.13
51.73%
-6.15
0.33%

All numbers in USD (except ratios and percentages)